Literature DB >> 25545867

Role of rituximab in the treatment of postpartum acquired haemophilia A: a systematic review of the literature.

Carlo Bonfanti1, Silvia Crestani1, Francesco Frattini1, Cinzia Sissa1, Massimo Franchini1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25545867      PMCID: PMC4614290          DOI: 10.2450/2014.0242-14

Source DB:  PubMed          Journal:  Blood Transfus        ISSN: 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  37 in total

1.  Single-center experience with rituximab as first-line immunosuppression for acquired hemophilia.

Authors:  J C Boles; N S Key; R Kasthuri; A D Ma
Journal:  J Thromb Haemost       Date:  2011-07       Impact factor: 5.824

Review 2.  Acquired inhibitors of coagulation factors: part I-acquired hemophilia A.

Authors:  Antonio Coppola; Emmanuel J Favaloro; Antonella Tufano; Matteo N D Di Minno; Anna Maria Cerbone; Massimo Franchini
Journal:  Semin Thromb Hemost       Date:  2012-06-27       Impact factor: 4.180

Review 3.  Inhibitors of propagation of coagulation (factors VIII, IX and XI): a review of current therapeutic practice.

Authors:  Massimo Franchini; Pier Mannuccio Mannucci
Journal:  Br J Clin Pharmacol       Date:  2011-10       Impact factor: 4.335

Review 4.  Acquired haemophilia A: a 2013 update.

Authors:  Massimo Franchini; Pier Mannuccio Mannucci
Journal:  Thromb Haemost       Date:  2013-09-05       Impact factor: 5.249

5.  Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry.

Authors:  Francesco Baudo; Peter Collins; Angela Huth-Kühne; Hervé Lévesque; Pascual Marco; László Nemes; Fabio Pellegrini; Lilian Tengborn; Paul Knoebl
Journal:  Blood       Date:  2012-05-22       Impact factor: 22.113

Review 6.  Therapeutic challenges in acquired factor VIII deficiency.

Authors:  Peter W Collins
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2012

Review 7.  Management of acquired haemophilia A.

Authors:  P W Collins
Journal:  J Thromb Haemost       Date:  2011-07       Impact factor: 5.824

8.  Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2).

Authors:  Peter Collins; Francesco Baudo; Paul Knoebl; Hervé Lévesque; László Nemes; Fabio Pellegrini; Pascual Marco; Lilian Tengborn; Angela Huth-Kühne
Journal:  Blood       Date:  2012-04-18       Impact factor: 22.113

9.  Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2).

Authors:  P Knoebl; P Marco; F Baudo; P Collins; A Huth-Kühne; L Nemes; F Pellegrini; L Tengborn; H Lévesque
Journal:  J Thromb Haemost       Date:  2012-04       Impact factor: 5.824

10.  Pregnancy-associated acquired haemophilia A: results from the European Acquired Haemophilia (EACH2) registry.

Authors:  L Tengborn; F Baudo; A Huth-Kühne; P Knoebl; H Lévesque; P Marco; F Pellegrini; L Nemes; P Collins
Journal:  BJOG       Date:  2012-08-20       Impact factor: 6.531

View more
  3 in total

1.  Clinical characteristics and outcomes of acquired hemophilia A: experience at a single center in Japan.

Authors:  Yoshiyuki Ogawa; Kunio Yanagisawa; Hideki Uchiumi; Takuma Ishizaki; Takeki Mitsui; Fumito Gouda; Masahiro Ieko; Akitada Ichinose; Yoshihisa Nojima; Hiroshi Handa
Journal:  Int J Hematol       Date:  2017-03-15       Impact factor: 2.490

Review 2.  Rituximab for eradicating inhibitors in people with acquired haemophilia A.

Authors:  Tracey Remmington; Sherie Smith
Journal:  Cochrane Database Syst Rev       Date:  2021-08-23

3.  Acquired Haemophilia A: A 15-Year Single-Centre Experience of Demography, Clinical Features and Outcome.

Authors:  Raisa Guerrero Camacho; María Teresa Álvarez Román; Nora Butta Coll; Damaris Zagrean; Isabel Rivas Pollmar; Mónica Martín Salces; Mercedes Gasior Kabat; Víctor Jiménez-Yuste
Journal:  J Clin Med       Date:  2022-05-11       Impact factor: 4.964

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.